Work

Treatment of Travelers’ Diarrhea: Randomized Trial Comparing Rifaximin, Rifaximin Plus Loperamide, and Loperamide Alone

Year: 2007

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2007.02.004

Authors: Herbert L. Dupont, Zhi–Dong Jiang, Jaime Belkind–Gerson, Pablo C. Okhuysen, Charles D. Ericsson, Shi Ke, David B. Huang, Margaret W. Dupont, Javier A. Adachi, F. Javier De La Cabada, David N. Taylor, Sridvya Jaini, Francisco Martinez Sandoval

Institutions: Baylor St. Luke's Medical Center, Baylor College of Medicine, The University of Texas Health Science Center at Houston, Instituto Nacional de Salud Pública, The University of Texas MD Anderson Cancer Center, Salix Pharmaceuticals (United States), Universidad Autónoma de Guadalajara

Language: English

Topic: Travel-related health issues

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources

Awards: G1081826082, General Clinical Research Center, Gene Polymorphisms Predisposing to Infectious Diarrhea, Texas Medical Center Digestive Diseases Center

OpenAlex ID: W2154977677

FWCI: 11.58

Cites: 36

Cited by: 92

Related to: 10